1. Home
  2. FEAM vs CING Comparison

FEAM vs CING Comparison

Compare FEAM & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 5E Advanced Materials Inc.

FEAM

5E Advanced Materials Inc.

HOLD

Current Price

$1.70

Market Cap

81.4M

Sector

Industrials

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$4.83

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEAM
CING
Founded
2016
2012
Country
United States
United States
Employees
35
13
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.4M
93.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FEAM
CING
Price
$1.70
$4.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$6.38
$34.50
AVG Volume (30 Days)
221.8K
400.0K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$3.20
52 Week High
$7.50
$11.89

Technical Indicators

Market Signals
Indicator
FEAM
CING
Relative Strength Index (RSI) 54.96 34.36
Support Level $1.66 $3.50
Resistance Level $1.80 $6.67
Average True Range (ATR) 0.17 0.46
MACD 0.03 -0.03
Stochastic Oscillator 73.98 2.55

Price Performance

Historical Comparison
FEAM
CING

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: